The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Recalls on a brand of broccoli and chocolate from December were recently upgraded to Class I, the highest risk level issued ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The U.S. Food and Drug Administration upgraded the classification of recalled broccoli sold at Walmart originally issued in ...

The Food and Drug Administration has upgraded its classification of a broccoli recall initially reported in late December, ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

A broccoli product sold at Walmart in Michigan was under recall. Now the FDA says the product may be considered deadly.

The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...